# McEwen Inc.: filings

MUX · NYSE · CIK 314203 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mux.md) · [Financials](/companies/mux/financials.md) · [Filings](/companies/mux/filings.md) · [Insiders](/companies/mux/insiders.md)

## Reports and events: 710 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 566, 4 329, 10-Q 53, 3 36, CORRESP 35, UPLOAD 32, DEFA14A 31, 10-K/A 23, 10-K 18, DEF 14A 18, 8-K/A 17, SC 13G/A 15, 4/A 14, 5 12, 424B5 10, EFFECT 10, SC 13D/A 7, S-3 6, S-8 6, PRE 14A 5, S-4/A 5, SC 13G 5, 10-Q/A 4, 424B3 4, ARS 4, S-4 4, SC 13D 4, 425 3, S-3/A 3, SD 3, 424B2 2, 5/A 2, FWP 2, NT 10-Q 2, PRER14A 2, S-8 POS 2, 144 1, 25 1, 3/A 1, 8-A12B 1, CERTNYS 1, DEFM14A 1, DEFR14A 1, NT 10-K 1, PREM14A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 20:15 ET | [8-K](/filings/0001104659-26-115508.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115508 |
| 2026-09-01 | 20:14 ET | [8-K](/filings/0001104659-26-104311.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-104311 |
| 2026-08-26 | 21:10 ET | [8-K](/filings/0001104659-26-101630.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-101630 |
| 2026-08-07 | 20:15 ET | [8-K](/filings/0001104659-26-092719.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092719 |
| 2026-08-05 | 21:29 ET | [10-Q](/filings/0001104659-26-091284.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091284 |
| 2026-06-30 | 21:06 ET | [8-K](/filings/0001104659-26-079394.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-079394 |
| 2026-06-24 | 21:20 ET | [10-K/A](/filings/0001104659-26-077359.md) | Annual report, amended, period 2025-12-31 | 0001104659-26-077359 |
| 2026-06-10 | 21:09 ET | [8-K](/filings/0001104659-26-072415.md) | 5.07 Shareholder vote results | 0001104659-26-072415 |
| 2026-06-02 | 20:45 ET | [8-K](/filings/0001104659-26-069531.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-069531 |
| 2026-06-01 | 21:14 ET | [8-K/A](/filings/0001104659-26-069016.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-069016 |
| 2026-05-22 | 21:23 ET | [8-K](/filings/0001104659-26-065819.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065819 |
| 2026-05-20 | 20:49 ET | [10-K/A](/filings/0001104659-26-064573.md) | Annual report, amended, period 2025-12-31 | 0001104659-26-064573 |
| 2026-05-08 | 12:19 ET | [8-K](/filings/0001104659-26-057585.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057585 |
| 2026-05-06 | 21:04 ET | [10-Q](/filings/0001104659-26-056349.md) | Quarterly report, period 2026-03-31 | 0001104659-26-056349 |
| 2026-05-05 | 20:45 ET | [8-K](/filings/0001104659-26-055698.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-055698 |
| 2026-04-24 | 20:30 ET | [DEF 14A](/filings/0001104659-26-048627.md) | Proxy statement, period 2026-06-04 | 0001104659-26-048627 |
| 2026-03-24 | 20:53 ET | [8-K](/filings/0001104659-26-033914.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-033914 |
| 2026-03-17 | 23:27 ET | [10-K](/filings/0001104659-26-028705.md) | Annual report, period 2025-12-31 | 0001104659-26-028705 |
| 2026-03-12 | 18:24 ET | [8-K](/filings/0001104659-26-026975.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-026975 |
| 2026-02-02 | 11:30 ET | [8-K](/filings/0001104659-26-008897.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-008897 |
| 2026-01-23 | 11:30 ET | [8-K](/filings/0001104659-26-005999.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-005999 |
| 2026-01-20 | 21:46 ET | [8-K](/filings/0001104659-26-005103.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-005103 |
| 2026-01-08 | 21:30 ET | [8-K](/filings/0001104659-26-002144.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002144 |
| 2025-12-23 | 22:03 ET | [8-K](/filings/0001104659-25-124286.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-124286 |
| 2025-12-22 | 21:30 ET | [8-K](/filings/0001104659-25-123759.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-123759 |
| 2025-11-10 | 11:07 ET | [8-K](/filings/0001104659-25-108712.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-108712 |
| 2025-11-07 | 11:08 ET | [8-K](/filings/0001104659-25-108062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-108062 |
| 2025-11-05 | 22:23 ET | [10-Q](/filings/0001104659-25-107117.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107117 |
| 2025-10-16 | 21:11 ET | [8-K](/filings/0001104659-25-100139.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-100139 |
| 2025-10-09 | 21:01 ET | [8-K](/filings/0001104659-25-098399.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-098399 |
| 2025-09-29 | 20:45 ET | [8-K](/filings/0001104659-25-094542.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-094542 |
| 2025-09-26 | 20:30 ET | [8-K](/filings/0001104659-25-093885.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-093885 |
| 2025-09-11 | 21:25 ET | [8-K](/filings/0001410578-25-002132.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001410578-25-002132 |
| 2025-09-04 | 20:02 ET | [8-K](/filings/0001104659-25-087459.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-087459 |
| 2025-08-15 | 20:16 ET | [8-K](/filings/0001104659-25-079252.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-079252 |
| 2025-08-08 | 20:59 ET | [8-K](/filings/0001104659-25-075735.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-075735 |
| 2025-08-06 | 21:14 ET | [10-Q](/filings/0001558370-25-010563.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010563 |
| 2025-07-31 | 20:09 ET | [8-K](/filings/0001104659-25-072689.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-072689 |
| 2025-07-10 | 22:17 ET | [8-K](/filings/0001104659-25-066759.md) | 7.01 Regulation FD disclosure | 0001104659-25-066759 |
| 2025-07-03 | 20:52 ET | [8-K](/filings/0001104659-25-065818.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-065818 |
| 2025-06-27 | 20:30 ET | [10-K/A](/filings/0001558370-25-008967.md) | Annual report, amended, period 2024-12-31 | 0001558370-25-008967 |
| 2025-06-25 | 20:16 ET | [8-K](/filings/0001104659-25-062578.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-062578 |
| 2025-05-13 | 20:20 ET | [8-K](/filings/0001104659-25-047845.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-047845 |
| 2025-05-07 | 21:02 ET | [10-Q](/filings/0001558370-25-006772.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006772 |
| 2025-05-02 | 20:05 ET | [10-K/A](/filings/0001558370-25-006193.md) | Annual report, amended, period 2024-12-31 | 0001558370-25-006193 |
| 2025-04-30 | 20:17 ET | [DEF 14A](/filings/0001104659-25-042532.md) | Proxy statement, period 2025-06-19 | 0001104659-25-042532 |
| 2025-03-24 | 20:47 ET | [8-K](/filings/0001104659-25-027270.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-027270 |
| 2025-03-14 | 21:19 ET | [10-K](/filings/0001558370-25-003017.md) | Annual report, period 2024-12-31 | 0001558370-25-003017 |
| 2025-02-11 | 22:24 ET | [8-K](/filings/0001140361-25-003863.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-003863 |
| 2025-02-06 | 22:24 ET | [8-K](/filings/0001140361-25-003461.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-003461 |

Page 1 of 15. [Older](/companies/mux/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:55 ET. No prices; not investment advice.